| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Revenue | $2.0M | +1040.7% |
| Cost of Revenue | $1.5M | +518.2% |
| Gross Profit | $457K | +744.9% |
| R&D Expense | $6.9M | +40.8% |
| SG&A Expense | $6.9M | -0.8% |
| Operating Income | -$12.0M | -19.2% |
| Pre-tax Income | -$11.9M | -18.6% |
| Net Income | -$11.9M | -18.6% |
| EPS (Basic) | -$0.65 |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.3M | -34.8% |
| Short-term Investments | $3.0M | +0.0% |
| Accounts Receivable | $33K | +0.0% |
| Inventory | $1.7M | +145.1% |
| Current Assets | $7.3M | -39.9% |
| Total Assets | $8.1M | -36.9% |
| Current Liabilities | $1.8M | -42.1% |
| Line Item | 2023-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$12.9M | -71.4% |
| Capital Expenditures | $384K | +39.6% |
| Investing Cash Flow | $2.6M | +181.7% |
| Financing Cash Flow | $7.4M | -38.5% |
| Free Cash Flow | -$13.3M | -70.3% |
| -3.2% |
| EPS (Diluted) | -$0.65 | -3.2% |
| Long-term Debt |
| $55K |
| -53.8% |
| Total Liabilities | $1.8M | -42.6% |
| Stockholders' Equity | $6.2M | -34.9% |